Patents Assigned to MAX ZELLER SOHNE AG
  • Use of Vitex agnus castus extracts for preparing a medicament
    Patent number: 8637099
    Abstract: The present invention relates to the use of fruit extract from Vitex agnus castus and/or one or more isolated and/or synthetically prepared bicylic diterpenes from Vitex agnus castus for the preparation of a medicament for the treatment of movement disorders. In particular, the invention is directed to the preparation of medicaments for treating Parkinson disease (PD), Periodic Limb Movement disorder (PLMD) and Restless Leg Syndrome (RLS), Huntington disease (HD) and Essential Tremor (ET), preferably familiar ET. Furthermore, the invention concerns a pharmaceutical composition comprising a fruit extract from Vitex agnus castus and/or one or more isolated and/or synthetically prepared bicylic diterpenes from Vitex agnus castus and at least one pharmaceutically compatible dopamine D2 and/or D3 receptor agonist.
    Type: Grant
    Filed: August 28, 2008
    Date of Patent: January 28, 2014
    Assignee: Max Zeller Sohne AG
    Inventor: Axel Brattström
  • PHARMACEUTICAL COMPOSITION CONTAINING ACTIVE VEGETABLE SUBSTANCES
    Publication number: 20140010900
    Abstract: The invention relates to a pharmaceutical composition containing active vegetable substances and a mixture made of a polymeric water-soluble and a polymeric water-insoluble matrix forming agent. Said pharmaceutical composition is suitable for the oral administration of active vegetable substances with delayed release.
    Type: Application
    Filed: December 21, 2011
    Publication date: January 9, 2014
    Applicants: MAX ZELLER SÖHNE AG, MEPHA SCHWEIZ AG
    Inventor: Marco Spitz
  • USE OF VITEX AGNUS CASTUS EXTRACTS FOR PREPARING A MEDICAMENT
    Publication number: 20100151059
    Abstract: The present invention relates to the use of fruit extract from Vitex agnus castus and/or one or more isolated and/or synthetically prepared bicylic diterpenes from Vitex agnus castus for the preparation of a medicament for the treatment of movement disorders. In particular, the invention is directed to the preparation of medicaments for treating Parkinson disease (PD), Periodic Limb Movement disorder (PLMD) and Restless Leg Syndrome (RLS), Huntington disease (HD) and Essential Tremor (ET), preferably familiar ET. Furthermore, the invention concerns a pharmaceutical composition comprising a fruit extract from Vitex agnus castus and/or one or more isolated and/or synthetically prepared bicylic diterpenes from Vitex agnus castus and at least one pharmaceutically compatible dopamine D2 and/or D3 receptor agonist.
    Type: Application
    Filed: August 28, 2008
    Publication date: June 17, 2010
    Applicant: MAX ZELLER SOHNE AG
    Inventor: Axel Brattström